PRICE T ROWE ASSOCIATES INC 13D and 13G filings for Denali Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-02-14 2:34 pm Sale |
2021-12-31 | 13G | Denali Therapeutics Inc. DNLI |
PRICE T ROWE ASSOCIATES INC | 4,635,433 3.700% |
-1,829,393![]() (-28.30%) |
Filing |
2021-02-16 12:24 pm Purchase |
2020-12-31 | 13G | Denali Therapeutics Inc. DNLI |
PRICE T ROWE ASSOCIATES INC | 6,464,826 5.300% |
6,464,826![]() (New Position) |
Filing |